Biomaxx
Semper sursum
- Joined
- Oct 12, 2025
- Posts
- 3,756
- Reputation
- 8,392
There has been some controversy over me posting this, and I want to clarify that under no circumstances will any compound sources and dosage advice be discussed. This is purely mechanistic and for high IQ users only.
KY-19382 has been on the rise recently and whilst it is still a relatively unknown compound, im going to explain it to yall
Addressing the mishap- i was js hella faded and started blabbing about cnp
(Js a bebeh)
As an apology this will be 5x better
---
Pathway Breakdown
KY-19382 runs through the CXXC5-DVL-Wnt axis. Dual mechanism: blocks CXXC5-DVL binding and inhibits GSK3β. Result is crazy β-catenin accumulation and TCF/LEF transcription .
CXXC5 is negative feedback on Wnt. KY-19382 removes it.
---
Bone Remodeling
Wnt/β-catenin drives osteoblast differentiation. CXXC5 is the off-switch Wnt induces to limit itself. KY-19382 cuts that feedback loop.
Effects:
- β-catenin stabilization ~ osteogenic gene transcription (ALP, BSP, FGF18)
- DMP-1 upregulation in osteocytes ~ enhanced mineralization
- Increased bone formation without PTH~type catabolic risk
CXXC5 knockout mice show elevated BMD, increased trabecular number, enhanced osteocyte network density. KY-19382 replicates this pharmacologically .
---
The Growth Plate
CXXC5-Wnt axis operates in epiphyseal chondrocytes. Estrogen induces CXXC5 during puberty, driving growth plate senescence. KY-19382 delays this.
Late puberty mice (7 weeks):
- 0.1 mg/kg IP, 2 weeks ~ increased growth plate height
- More proliferative and hypertrophic chondrocytes per column
- Delayed senescence, extended growth window
Early puberty mice (3 weeks):
- Expanded proliferative and hypertrophic zones
- Nuclear β-catenin accumulation in chondrocytes
- Elevated COL2A1, RUNX2, MMP13
GSK3β inhibition drives early maturation. CXXC5-DVL disruption specifically blocks late-pubertal senescence .
---
Collagen & Soft Tissue
Wnt/β-catenin in dermal (skin) fibroblasts:
- Collagen I synthesis increase
- α-SMA expression ~ myofibroblast activation
- Keratin 14 upregulation
- PCNA increase
Wound healing models show accelerated fibroblast/keratinocyte migration, increased collagen deposition, enhanced neo-epidermis formation. Stem cell marker activation .
(Bad quality sorry)
---
Hair Growth
Hair follicles require Wnt for dermal papilla hair-inducing activity and anagen maintenance.
KY-19382 in DP cells:
- ALP activity elevation
- PCNA upregulation
- Nuclear β-catenin accumulation
In vivo :
- Superior to minoxidil
- Accelerated telogen to anagen transition
- Bulge stem cell activation (Ki67+, PCNA+, Keratin 15+)
- Wound-induced hair follicle neogenesis
Wnt/β-catenin maintains DP signaling and HFSC activation, bypassing negative feedback limits on cycling.
---
Vascular & Metabolic
Wnt/β-catenin in endothelial cells:
- Enhanced nutrient delivery to remodeling sites
- Improved tissue perfusion
- Metabolic reprogramming via PKM2 induction
---
The Purple Eye Effect
KY-19382 can make eyes appear purple during usage. Wnt/β-catenin-driven vascular remodeling in iris. Consistent marker of target engagement.
---
Summary
KY-19382 is a negative feedback disruptor, not a direct Wnt agonist. Releases CXXC5 brake rather than overaccelerating pathway.
Effects:
Bone formation leads to the differentiation , the creation of bone minerals, and the growth of the growth plate. Soft tissue repair involves collagen production, wound healing, and hair growth cycles. Improved blood flow helps with nutrient delivery and overall blood circulation. This two-part process provides immediate activation and a lasting improvement by interrupting feedback loops.
---
Sources:
https://pmc.ncbi.nlm.nih.gov/articles/PMC8251890/?sharetype=link
https://pmc.ncbi.nlm.nih.gov/articles/PMC10380997/?sharetype=link
https://pmc.ncbi.nlm.nih.gov/articles/PMC4818757/?sharetype=link
https://pmc.ncbi.nlm.nih.gov/articles/PMC4423189/?sharetype=link
https://pmc.ncbi.nlm.nih.gov/articles/PMC6458850/?sharetype=link
KY-19382 has been on the rise recently and whilst it is still a relatively unknown compound, im going to explain it to yall
Addressing the mishap- i was js hella faded and started blabbing about cnp
(Js a bebeh)
As an apology this will be 5x better
---
Pathway Breakdown
KY-19382 runs through the CXXC5-DVL-Wnt axis. Dual mechanism: blocks CXXC5-DVL binding and inhibits GSK3β. Result is crazy β-catenin accumulation and TCF/LEF transcription .
CXXC5 is negative feedback on Wnt. KY-19382 removes it.
---
Bone Remodeling
Wnt/β-catenin drives osteoblast differentiation. CXXC5 is the off-switch Wnt induces to limit itself. KY-19382 cuts that feedback loop.
Effects:
- β-catenin stabilization ~ osteogenic gene transcription (ALP, BSP, FGF18)
- DMP-1 upregulation in osteocytes ~ enhanced mineralization
- Increased bone formation without PTH~type catabolic risk
CXXC5 knockout mice show elevated BMD, increased trabecular number, enhanced osteocyte network density. KY-19382 replicates this pharmacologically .
---
The Growth Plate
CXXC5-Wnt axis operates in epiphyseal chondrocytes. Estrogen induces CXXC5 during puberty, driving growth plate senescence. KY-19382 delays this.
Late puberty mice (7 weeks):
- 0.1 mg/kg IP, 2 weeks ~ increased growth plate height
- More proliferative and hypertrophic chondrocytes per column
- Delayed senescence, extended growth window
Early puberty mice (3 weeks):
- Expanded proliferative and hypertrophic zones
- Nuclear β-catenin accumulation in chondrocytes
- Elevated COL2A1, RUNX2, MMP13
GSK3β inhibition drives early maturation. CXXC5-DVL disruption specifically blocks late-pubertal senescence .
---
Collagen & Soft Tissue
Wnt/β-catenin in dermal (skin) fibroblasts:
- Collagen I synthesis increase
- α-SMA expression ~ myofibroblast activation
- Keratin 14 upregulation
- PCNA increase
Wound healing models show accelerated fibroblast/keratinocyte migration, increased collagen deposition, enhanced neo-epidermis formation. Stem cell marker activation .
(Bad quality sorry)
---
Hair Growth
Hair follicles require Wnt for dermal papilla hair-inducing activity and anagen maintenance.
KY-19382 in DP cells:
- ALP activity elevation
- PCNA upregulation
- Nuclear β-catenin accumulation
In vivo :
- Superior to minoxidil
- Accelerated telogen to anagen transition
- Bulge stem cell activation (Ki67+, PCNA+, Keratin 15+)
- Wound-induced hair follicle neogenesis
Wnt/β-catenin maintains DP signaling and HFSC activation, bypassing negative feedback limits on cycling.
---
Vascular & Metabolic
Wnt/β-catenin in endothelial cells:
- Enhanced nutrient delivery to remodeling sites
- Improved tissue perfusion
- Metabolic reprogramming via PKM2 induction
---
The Purple Eye Effect
KY-19382 can make eyes appear purple during usage. Wnt/β-catenin-driven vascular remodeling in iris. Consistent marker of target engagement.
---
Summary
KY-19382 is a negative feedback disruptor, not a direct Wnt agonist. Releases CXXC5 brake rather than overaccelerating pathway.
Effects:
Bone formation leads to the differentiation , the creation of bone minerals, and the growth of the growth plate. Soft tissue repair involves collagen production, wound healing, and hair growth cycles. Improved blood flow helps with nutrient delivery and overall blood circulation. This two-part process provides immediate activation and a lasting improvement by interrupting feedback loops.
---
Sources:
https://pmc.ncbi.nlm.nih.gov/articles/PMC8251890/?sharetype=link
https://pmc.ncbi.nlm.nih.gov/articles/PMC10380997/?sharetype=link
https://pmc.ncbi.nlm.nih.gov/articles/PMC4818757/?sharetype=link
https://pmc.ncbi.nlm.nih.gov/articles/PMC4423189/?sharetype=link
https://pmc.ncbi.nlm.nih.gov/articles/PMC6458850/?sharetype=link
